在格勒诺布尔-伊泽尔投资的理由
搜索
Events
-
EUROMEDTECH 2012
-
European Workshop on Nano Transparent Conductive Materials
-
14th Leti Annual Review
-
ISSAC 2012
-
Metals Homeostasis 5th International IMBG Meeting
-
2012 International Semiconductor Conference Dresden-Grenoble
生物技术
格勒诺布尔-伊泽尔在生命科学领域的发展前沿占据着令人羡慕的领先优势。在欧洲地区难得的多学科共同发展的背景下，格勒诺布尔成功实现了将当地生命科学的知识与其在纳米技术领域的卓越技术的结合。
Grenoble and Lyon boast a high-powered talent pool, thanks to complementary assets in medicine, biology, chemistry, IT, nanotechnology and physics. Their common ambition is to become one of Europe’s top five biotechnology sites in the next few years. Grenoble-Isère: new diagnostic tools for new approaches to treatment.
Key players in biotechnology
A full and integrated network of players has been established in the field of biotechnology. This powerful network provides a wide range of services, from training tomorrow’s researchers to mass production of innovative solutions.
Major industrial market leaders such as BD
, Roche
. Innovative and dynamic SMEs such as Tornier
, Px'Therapeutics
. Academic excellence: Grenoble-INP
, UJF
, etc. Major international research facilities such as ESRF
, ILL
Joining forces in Grenoble-Isère to work together.
Federative projects
Working together to achieve more; making the most of individual differences to push collective limits; creating synergy to generate more added value: this is the spirit bonding companies, universities and research laboratories in Grenoble-Isère. Supported by proactive local authorities, these establishments have rallied round several major projects. The Lyonbiopole competitive cluster, the Nanobio platform and Clinatec all illustrate the capacity of Grenoble-Isère’s biotechnology players to mobilize and work together.
